Huang X - Search Results

1

Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy.

Mei H, Chen F, Han Y, Hou M, Huang H, Huang X, Li Y, Liang A, Liu Q, Niu T, Peng J, Qian W, Song Y, Wang J, Wang Y, Wu D, Xu K, Yang L, Yang R, Zhang L, Zhang L, Zhang X, Zhang X, Zhao W, Han W, Hu Y. Mei H, et al. Among authors: huang h, huang x. Chin Med J (Engl). 2022 Jul 20;135(14):1639-1641. doi: 10.1097/CM9.0000000000002288. Chin Med J (Engl). 2022. PMID: 35984103 Free PMC article. No abstract available.

2

Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.

Liu D, Yan C, Xu L, Wang Y, Han W, Zhang X, Liu K, Huang X. Liu D, et al. Among authors: huang x. Biol Blood Marrow Transplant. 2010 Nov;16(11):1567-75. doi: 10.1016/j.bbmt.2010.05.001. Epub 2010 Sep 15. Biol Blood Marrow Transplant. 2010. PMID: 20546909 Free article. Clinical Trial.

3

Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes.

Zhang X, Fu H, Xu L, Liu D, Wang J, Liu K, Huang X. Zhang X, et al. Among authors: huang x. Biol Blood Marrow Transplant. 2011 Feb;17(2):274-80. doi: 10.1016/j.bbmt.2010.09.007. Epub 2010 Sep 18. Biol Blood Marrow Transplant. 2011. PMID: 20854919 Free article.

4

A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy.

Huang X, Wang F, Chen Y, Liu T, Wang J, Hu J, Jie J, Chen F, Wang S, Shen Z, Yu L, Yu K, Liang Y. Huang X, et al. Future Microbiol. 2012 Feb;7(2):201-9. doi: 10.2217/fmb.11.158. Future Microbiol. 2012. PMID: 22324990 Clinical Trial.

5

Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.

Huang X, Chen H, Han M, Zou P, Wu D, Lai Y, Huang H, Chen X, Liu T, Zhu H, Wang J, Hu J. Huang X, et al. Among authors: huang h. Biol Blood Marrow Transplant. 2012 Oct;18(10):1509-16. doi: 10.1016/j.bbmt.2012.03.014. Epub 2012 Mar 30. Biol Blood Marrow Transplant. 2012. PMID: 22469884 Free article. Clinical Trial.

6

Molecular monitoring and stepwise preemptive therapy for Epstein-Barr virus viremia after allogeneic stem cell transplantation.

Liu Q, Xuan L, Liu H, Huang F, Zhou H, Fan Z, Zhao K, Wu M, Xu L, Zhai X, Zhang F, Liu C, Sun J, Huang X. Liu Q, et al. Among authors: huang f, huang x. Am J Hematol. 2013 Jul;88(7):550-5. doi: 10.1002/ajh.23452. Epub 2013 May 30. Am J Hematol. 2013. PMID: 23564232 Free article.

7

Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantation.

Xuan L, Jiang X, Sun J, Zhang Y, Huang F, Fan Z, Guo X, Dai M, Liu C, Yu G, Zhang X, Wu M, Huang X, Liu Q. Xuan L, et al. Among authors: huang f, huang x. Transplantation. 2013 Sep;96(6):560-6. doi: 10.1097/TP.0b013e31829d38af. Transplantation. 2013. PMID: 23842192

8

Comparable outcomes of partially matched related and matched related allogeneic hematopoietic cell transplantation following reduced-intensity conditioning in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Wu X, He G, Fa Y, Ma X, Wu D, Ai H, Huang X, Han Y, Xu Y, Sun A, Wu Q, Tang X, Fu Z. Wu X, et al. Among authors: huang x. Int J Hematol. 2013 Oct;98(4):456-62. doi: 10.1007/s12185-013-1412-y. Epub 2013 Aug 24. Int J Hematol. 2013. PMID: 23975518

9

[Analysis of risk factors for secondary cytopenia after allogeneic hematopoietic stem cell transplantation].

Lin Z, Kong Y, Wang Y, Zhang X, Liu D, Xu L, Huang X. Lin Z, et al. Among authors: huang x. Zhonghua Xue Ye Xue Za Zhi. 2014 Jan;35(1):4-8. doi: 10.3760/cma.j.issn.0253-2727.2014.01.002. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24602722 Chinese.

10

Interferon α: the salvage therapy for patients with unsatisfactory response to minimal residual disease-directed modified donor lymphocyte infusion.

Mo X, Zhao X, Xu L, Liu D, Zhang X, Chen H, Wang Y, Huang X. Mo X, et al. Among authors: huang x. Chin Med J (Engl). 2014;127(14):2583-7. Chin Med J (Engl). 2014. PMID: 25043071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44,183 results

Search Page